Posted on

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Inbiotec Medical Devices, the new line of healthcare products developed by the IT Pharma group, is bringing its first product to market: Inbiotec Amber, a new injectable comprising 1.1% hyaluronic acid and 1.6% succinic acid. In a paper entitled: A new concept in mesotherapy: Discover the benefits of succinic acid, Doctor Latorre will explain the benefits of this active ingredient sourced from amber.

With this new line of healthcare products for aestheticians and dermatologists, IT Pharma aims to provide professionals with a safe, innovative product that stands out due to its combination of top quality ingredients.

The presentation is set to take place on Friday 22nd in Malaga, Conference Room 1 and will count on the presence of Dr. Pilar Garcia-Las Heras as moderator.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

8th Cosmetic Medicine Congress of Galicia

8th Cosmetic Medicine Congress of Galicia

Last weekend, IT Pharma took part in the 8th Cosmetic Medicine Congress of Galicia, held in the Island of La Toja in Galicia, Spain.

IT Pharma took part in the Cosmetic Medicine Congress held in La Toja, with a paper on rhinoplasty with PDO threads, presented by Dr. Pérez Díaz..

Last weekend, IT Pharma took part in the 8th Cosmetic Medicine Congress of Galicia, held in the Island of La Toja in Galicia, Spain. The congress, organised by the Cosmetic Medicine Association of Galicia (ASMEGA), featured a paper presented on the Saturday by Dr Juan Miguel Pérez Díaz on rhinoplasty with Aqulift lifting threads, to an audience of almost one hundred cosmetic professionals.

Furthermore, the group’s partners, TOV Medical and Real Lasting, presented papers on Prostrolane Inner B and Dr. CYJ, which received an excellent response, with a packed house at both presentations.

The congress gala dinner was attended by almost 200 doctors and professionals from the sector.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

16th AMWC Aesthetic and Antiaging Medicine World Congress

16th AMWC Aesthetic and Antiaging Medicine World Congress

IT Pharma presented its latest advances at the 16th Aesthetic and Antiaging Medicine World Congress (AMWC)

IT Pharma presented its latest advances in the Principality of Monaco Grimaldi Forum.

Last week, the 16th Aesthetic and Antiaging Medicine World Congress (AMWC) was held in Monaco, in the Principality’s Grimaldi Forum. IT Pharma participated for three days in the most important health and beauty event in the world. Hundreds of companies, doctors and aesthetic healthcare professionals came together to discover the latest advances and techniques in the sector.

IT Pharma, in collaboration with IT Pharma Mexico and IT Pharma Asia, had their own stand in the Diaghilev Hall, where they served hundreds of professionals looking for the latest advances in the field. The Navarrese company presented its Turtlepin penetration system as the main new change, which received considerable interest from attendees.

In turn, the Caregen laboratories attending the congress introduced the new Prostrolane® lipolytic facial with biomimetic peptides. IT Pharma is the exclusive importer of this product, and it is distributed in Spain by TOV Medical.

The central theme of this year’s congress was patient safety as a top priority, one of the values with which the Navarrese group is highly committed.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma Mexico in the 15th Mexican Aesthetic and Anti-Ageing Scientific Congress

IT Pharma Mexico in the 15th Mexican Aesthetic and Anti-Ageing Scientific Congress

Last Friday, March 2, the 15th Mexican Congress of Aesthetic Medicine and Anti-Aging was held at the Pepsi Center in Mexico City. The delegation of IT Pharma Mexico collaborated as Platinum Sponsor of the congress, in addition to participating in the presentations of Dr. Pérez Díaz, regular collaborator of the group in Spain.

The Mexican branch of IT Pharma participated as the Platinum Sponsor for the event .

On Friday 2nd March, the 15th Mexican Aesthetic and Anti-Ageing Scientific Congress took place in the Pepsi Center in Mexico City. The Mexican branch of IT Pharma took part as the Platinum Sponsor for the congress, and also participated in the speeches by Dr Pérez Díaza regular collaborator of the group in Spain..

20 international and 11 Mexican speakers took the floor in the Congress, updating their professional colleagues with a programme acknowledged by the National Autonomous University of Mexico.

Dr Pérez Díaz, from the Pérez Díaz Clinic of Alicante, participated with two speeches about Athenea, Re Up and Bivectorial combined PDO Threading techniques with Hyaluronic acid using products such as Revofil, distributed in Mexico and Spain by the Navarran group.

In turn, the IT Pharma Mexico stand had a spectacular demonstration cubicle, where attendees could see the brand’s entire product range and their different uses.

Finally, on Sunday 4th March, a master class was given for a select group of professionals, led by Dr Pérez Díaz on the IT Pharma Mexico facilities, where training was given on the aforementioned techniques. Certificates were given to all those completing the course.

Once again, the synergies forged between IT Pharma and its Mexican colleagues produced yet another successful international collaboration, contributing to the on-going success of the professionals involved and the products they use.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma attends the SEME congress

IT Pharma attends the SEME congress

IT Pharma attended the SEME 2018 to present its latest news, among which were Prostrolane Inner B and Turtlepin

Over 2,000 medical experts attended the Spanish aesthetic medicine congress.

CYet another year running, IT Pharma attended the Spanish Aesthetic Medicine Congress, which took place from 22nd to 24th February in Malaga, organised by the Spanish Society of Aesthetic Medicine (SEME). Scientists specialising in aesthetic medicine attended the three-day Congress Fair, which offered speeches, presentations and stands with representatives from Spain’s main brands.

One of the most eagerly-awaited exhibitions was that of Prostrolane Inner B, a product imported by IT Pharma and commercialised by TOV Medical in Spain. The speech was given by Doctor Juan Miguel Pérez Díaz, from the Pérez Díaz Clinic in Alicante. Over a hundred people attended the presentation about one of the most talked about products in the congress.

The Navarran brand also revealed the new Turtlepin medical device, a head that enables the product or solution to be introduced via hollow hypodermic needles.

This congress is a national and international benchmark, which unites over 2,000 participants each year. According to figures released by the organising company, the number of congress members rose by 10% compared to the previous year, demonstrating the healthy outlook of the sector.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma attends the IMCAS World Congress in Paris

IT Pharma attends the IMCAS World Congress in Paris

IT Pharma attended the IMCAS World Congress in Paris to introduce Prostrolane Inner B of Caregen

The Navarran group made the most of the congress to sign the exclusive distribution agreement in Spain and Mexico for the Prostrolane line by Caregen.

On 1st February, IT Pharma attended the IMCAS WORLD CONGRESS on aesthetic medicine, which took place in Paris, where it collaborated by exhibiting and introducing Prostrolane Inner B., by Caregen Co., assisted by Dr Chung, CEO of the Korean firm.

Doctor Juan Miguel Pérez from the Pérez Díaz Clinic – a regular collaborator of the group – gave a speech about the product and revealed ten clinical cases in which the effectiveness and quality of Inner B. was left undisputable, accompanying other collaborating medical professionals from the Korean group.

Taking full advantage of the visit to the French capital, an importation and exclusive distribution agreement was signed with Caregen for the Prostrolane line. The agreement was signed by Dr Chung and the IT Pharma management, which has reached an agreement with TOV Medical, collaborators in distribution in Spain, who have been given the responsibility for marketing Inner B. within Spain.

The congress concluded with a gala dinner, attended by all the trusted distributers and doctors from the Korean firm.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment